Biological Vaccines

Comirnaty

Payments companies reported to CMS as associated with Comirnaty. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$5.0Massociated payments (2023-2025)

90,941clinicians with associated payments

6companies reporting

By year

2023 $2.4M

2024 $1.3M

2025 $1.3M

Payments reported as associated with Comirnaty, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family Medicine $1.0M

Internal Medicine $719K

Family $708K

Pediatrics $456K

Physician Assistant $319K

Infectious Disease $188K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Comirnaty

These are the largest totals companies reported as associated with Comirnaty. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Stephen Thomas	Syracuse, NY	Infectious Disease	$64,794.38
Ruth Carrico	Chicago, IL	Family	$51,302.03
Christian Sandrock	Sacramento, CA	Internal Medicine	$44,914.02
Octavio Ramilo	Memphis, TN	Pediatric Infectious Diseases	$40,906.10
Julio Ramirez	Louisville, KY	Infectious Disease	$36,453.43
David Weber	Chapel Hill, NC	Pediatric Infectious Diseases	$29,247.53
Robert Frenck	Cincinnati, OH	Pediatric Infectious Diseases	$27,430.05
Wendy Wright	Amherst, NH	Family	$26,634.47
Brett Gilbert	Wynnewood, PA	Infectious Disease	$25,997.78
Robert Belshe	Saint Louis, MO	Infectious Disease	$25,900.00

Prescribed Comirnaty?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.